Facial Hemangiomas May Signal PHACE

Early recognition of segmental facial lesions prompted diagnosis and multidisciplinary care in an infant with multisystem involvement

By
Andrea Surnit
April 14, 2026
3 min

Conexiant

At a Glance

Category	Detail
Condition	PHACE syndrome, a rare neurocutaneous disorder characterized by large segmental infantile hemangiomas and associated congenital anomalies
Key Mechanisms	Large segmental facial hemangiomas plus major or minor extracutaneous anomalies including posterior fossa brain malformations, arterial anomalies, cardiac defects, and eye abnormalities
Target Population	Infants presenting with large segmental facial hemangiomas
Care Setting	Multidisciplinary clinical setting involving dermatology, ophthalmology, genetics, neurology, and cardiology

Key Highlights

Diagnosis requires a large facial hemangioma plus at least one major or two minor extracutaneous criteria.
Associated anomalies include cerebrovascular malformations, structural brain abnormalities, cardiac defects, and ocular involvement.
Early recognition and multidisciplinary management are critical to reduce stroke risk and improve clinical outcomes.

Guideline-Based Recommendations

Diagnosis

Evaluate infants with large segmental facial hemangiomas for PHACE syndrome using consensus diagnostic criteria.
Perform imaging studies including MRI to identify brain malformations and vascular anomalies.
Assess for cardiac defects and ocular abnormalities as part of comprehensive evaluation.

Management

Initiate aspirin at 4 mg/kg/day to reduce stroke risk in patients with cerebrovascular anomalies.
Start propranolol therapy, titrated carefully (e.g., from 0.5 to 3 mg/kg/day), with close monitoring.
Use corticosteroids such as prednisolone for short courses as indicated.
Apply topical timolol for ocular hemangiomas to reduce periocular swelling.

Monitoring & Follow-up

Regular clinical follow-up to assess hemangioma regression and developmental milestones.
Ongoing multidisciplinary evaluation to monitor cerebrovascular status and cardiac function.
Careful observation for potential neurologic complications including stroke.

Risks

Elevated risk of arterial ischemic stroke due to cerebrovascular malformations.
Potential long-term neurologic complications if diagnosis and management are delayed.

Patient & Prescribing Data

Infants diagnosed with PHACE syndrome presenting with large segmental facial hemangiomas and associated anomalies

Combination therapy with aspirin, propranolol, corticosteroids, and topical timolol can reduce hemangioma size, improve ocular symptoms, and mitigate stroke risk.

Clinical Best Practices

Prompt recognition of large segmental facial hemangiomas as a potential marker for PHACE syndrome.
Early multidisciplinary evaluation including dermatology, neurology, cardiology, ophthalmology, and genetics.
Timely initiation of targeted therapies to improve clinical outcomes and reduce complications.
Close monitoring of vascular anomalies and developmental progress.